Yemaachi Biotechnology
PrivateLast Round
Grant
Mar 6, 2024
Est. Valuation
$1.79M
Total Funding Raised
$4.13M
Momentum Score
25 /100
Company Overview
Yemaachi Biotechnology is a Ghanaian precision oncology company founded in 2020. The company is focused on diversifying cancer research and diagnostics by building a comprehensive Pan-African genomic and clinical database. Using immunogenomics, bioinformatics, and artificial intelligence, Yemaachi aims to develop next-generation cancer diagnostics and therapeutics that are more effective for diverse populations, particularly those of African descent. The company offers clinical testing services, including NGS-based screening, and collaborates with global pharmaceutical companies and research institutions to advance precision oncology. Yemaachi has raised a $3 million seed round and has received grants, including from the Bill and Melinda Gates Foundation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yemaachi Biotechnology Comps
Public and private peers based on sector, stage, and business model.
Yemaachi Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 6, 2024 | ||||
| Seed | Mar 21, 2022 | ||||
| Grant | Nov 9, 2021 | ||||
| Accelerator | Aug 9, 2021 |
Yemaachi Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Cancer Grand Challenges | Grant |
| LoftyInc Capital Management | Seed |
| LifeLine Family Heritage Fund | Seed |
| Cancer Research UK | Grant |
| Y Combinator | Seed, Accelerator |
| V-Square Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2025
Launching The African Cancer Atlas (TACA) together.
- Feb 18, 2025
Launched The African Cancer Atlas in partnership with Roche.
Yemaachi Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Yemaachi Biotechnology's valuation, stock price, and market status.
